inbrx-109
inhibrx
['inbrx-109 ', 'sarcoma']
inbrx-109 , a death receptor5 agonist to treat chondrosarcoma led to a disease control rate of 87.1% (27/31; durable clinical benefit, 40.7% [11/27]), including 2 partial responses, and median pfs of 7.6 months #chondrosarcoma #asco23 
Director Pediatric Hematology Oncology & Bone Marrow Transplant, Medanta The Medicity . RT are not endorsement and views are my own